Anavex Life Sciences Corp (AVXL)

[frrol]

Regarding the PK data that the company is waiting for before releasing Part B 12-week interim results, I did some DD:

1. In their December 29th 2015 Fiscal Results PR the company listed an upcoming milestone: "Report pharmacokinetics and pharmacodynamics (PK/PD) data for PART A of the Phase 2a trial."

2. In their February 8th 2016 Q1 Fiscal Results PR the company no longer listed that as an upcoming milestone.

3. In their February 26th 2016 Epilepsy Pipeline Conference presentation, it read "[Part A] Additional data to be presented", which likely meant the PK data as well as dosage correlation.

4. In their March 12th 2016 AAT presentation, it said "PK Study - completed." (Though it wasn't presented here; perhaps in one of their papers.)

This likely means that sometime between 3-4 months after they were ready to present the Part A test results, they had the Part A PK results. Assuming the Part B 12-week test results were ready in early Feb (3 months after the Nov 7th Part A presentation), I think we can expect the PK data 3-4 months after that. That means early May-June. So I'm thinking the PK results are likely ready now. A 3-4 month timeframe for PK data makes sense. So I'm pretty confident the company will be announcing the 12-week results soon, or at the very next scientific meeting.